Tirzepatide Brand Names: Mounjaro vs. Zepbound — Which to Ask For

Tirzepatide exists under two brand names: Mounjaro and Zepbound. Both are manufactured by Eli Lilly, both contain identical active ingredient at identical doses, and both work through the same GLP-1/GIP dual mechanism. The only structural difference is the FDA approval each carries — and that difference has enormous practical consequences for coverage and cost.

The dose structure (same for both)

Both Mounjaro and Zepbound are available in the following weekly injection doses:

• 2.5 mg (starting/titration dose)
• 5 mg
• 7.5 mg
• 10 mg
• 12.5 mg
• 15 mg (maximum dose)

The titration protocol — starting at 2.5 mg and increasing every four weeks as tolerated — is the same regardless of which brand name is on the box.

Mounjaro: the diabetes label

Mounjaro was approved in May 2022 for type 2 diabetes management. If you have type 2 diabetes, this is the on-label product. Plans that cover tirzepatide for diabetes will reference Mounjaro specifically. The Lilly savings card for Mounjaro can reduce copays for eligible commercially insured patients.

Zepbound: the weight management label

Zepbound was approved in November 2023 for chronic weight management. If you do not have diabetes, this is the correct on-label product for obesity treatment. Coverage varies significantly — some commercial plans include it, others exclude it or require prior authorisation. Medicare's coverage of Zepbound as a weight-management drug has been limited under traditional Part D rules.

Which brand to ask for — a simple decision tree

• You have type 2 diabetes and your plan covers Mounjaro → Ask for Mounjaro. It is on-label, covered, and identical to Zepbound.
• You have obesity without diabetes and your plan covers Zepbound → Ask for Zepbound. It is the correct on-label product.
• Your plan covers neither → Compounded tirzepatide through a reputable telehealth provider is the most accessible cash-pay option. The active molecule is the same.
• You have both diabetes and obesity → Discuss with your prescriber which label gives you better access under your specific plan.

What happens if you get the wrong brand

If your plan covers Mounjaro for diabetes and your prescriber writes Zepbound for weight management, your claim will likely be denied. The reverse is also true. Since the drugs are pharmacologically identical, this is frustrating — but it is how the US coverage system works. Getting the brand name right on the prescription matters.

This content is educational. Work with your prescriber and insurer to confirm which brand is covered under your specific plan before filling a prescription.